Alpha Tau Medical Ltd. Ordinary Shares (DRTS) Stock Price, Quote & AI Analysis
Live DRTS stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Alpha Tau Medical Ltd. Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Alpha Tau Medical Ltd. Ordinary Shares (DRTS), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Alpha Tau Medical Ltd. Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Alpha Tau Medical Ltd. Ordinary Shares Overview
Company information
Company Overview
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Alpha Tau Medical Ltd. Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...